시장보고서
상품코드
1309864

핵산 샘플 조제 시장 - 세계 산업 규모, 점유율, 동향, 경쟁, 기회, 예측(2018-2028년)

Nucleic Acid Sample Preparation Market- Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Technology, By Therapeutic Area, By Application, By End Users,By Region and Competition

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 116 Pages | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

핵산 샘플 조제 시장은 2024-2028년 예측 기간 동안 놀라운 CAGR을 기록할 것으로 예상됩니다.

이러한 배경에는 다양한 치료 영역에서 핵산 분자의 활용이 확대되고 있는 점 등이 있습니다.

생명과학 분야 연구개발의 성장

생명과학 분야의 연구 확대를 위한 정부, 학계 등의 투자 증가는 핵산 샘플 조제 시장의 수요를 촉진할 것으로 예상됩니다. 예를 들어, 2022년 2월 Brightlamp Inc.와 Purdue-affiliated Amplified Sciences LLC는 Purdue Foundry Investment Fund로부터 생명과학 발전을 위한 연구개발을 위해 각각 약 25만 달러의 보조금을 받았습니다. 를 지원받았습니다. 앰플리파이드 사이언스는 암 및 기타 질병의 사전 진단을 위한 첨단 기술을 연구하고 있습니다. 마찬가지로 브라이트 램프(Brightlamp)는 머신러닝과 컴퓨터 비전을 활용해 의료 서비스를 강화하고 개선하는 기업입니다.

치료 분야에서의 핵산 활용 확대

신속한 질병 진단에 대한 수요 증가와 여러 환자 치료에 대한 진단 정보의 필요성으로 인해 명확한 분자 절차가 개발되어 진단 절차에 따라 핵산 샘플 추출이 증가하여 핵산 샘플 조제 시장에 유리한 수요를 제공 할 것으로 예상됩니다. 또한, 암과 같은 만성 질환의 유병률이 증가함에 따라 분자 수준에서 진단의 필요성이 증가함에 따라 핵산 샘플 추출 및 준비에 대한 수요 증가가 예측 기간 동안 시장 성장을 주도하고 있습니다. 또한, 샘플 조제는 안전 보장 수준과 맞춤형 치료의 성공 사례로 인해 정밀 의학에서 필수적인 응용 분야입니다.

핵산 추출 시스템에 대한 수요 증가

핵산 분리/추출은 분자 진단 및 모든 분자 실험실 연구에서 가장 기본적인 단계이며, 시료 추출에 사용되는 장비와 방법이 다양해짐에 따라 확대되고 있습니다. 자동화된 핵산 추출 시스템의 가용성은 핵산 샘플 조제 시장의 성장을 촉진하고 있습니다. 또한, 자동화의 발전은 최소한의 오류율로 여러 샘플을 동시에 실행하고 혈청, 조직, 세포 배양과 같은 다양한 샘플에서 핵산을 추출할 수 있기 때문에 핵산 샘플 조제 시장을 가속화할 것으로 예상됩니다. 예를 들어, 2020년 2월, 시장 기업 Covaris Inc.는 truXTRAC-PCR Direct viral RNA Extraction kit와 truXTRAC Viral RNA Extraction kit를 포함한 인두 또는 비강 닦음액 채취 장치를 통한 바이러스 RNA 추출을 위한 두 가지 새로운 키트를 발표했습니다.

차세대 시퀀서 수요 확대(다운스트림 애플리케이션)

질병에서 차세대 시퀀싱(NGS)에 대한 수요가 증가함에 따라 핵산 샘플 조제 시장의 수요를 촉진하고 있습니다. 유전자 또는 표적 염기서열은 관심 있는 유전자 또는 질병 인자를 운반하는 유전자 또는 표적 염기서열을 식별하여 질병 진단에 사용할 수 있습니다. 또한, 표적 시퀀싱을 통해 연구자들은 특정 관심 유전자, 코드 영역 또는 염색체 부문을 표적으로 삼을 수 있으며, 이는 정확하고 신속하며 정밀한 데이터 수집을 위한 시퀀싱에 유용한 기술입니다. 염기서열 분석용 키트와 개발된 시약의 가용성은 예측 기간 동안 시장 성장을 지원하고 핵산 샘플 조제 시장을 강화할 것으로 보입니다.

최근 동향

주요 시장 진입자들은 신제품을 발표하며 제품 포트폴리오를 확장하고 있습니다. 예를 들어, 2020년 2월 미로큘러스(Miroculus Inc.)는 중첩 생성 시퀀스 라이브러리 준비와 같은 복잡한 프로토콜을 자동화, 단순화, 소형화할 수 있는 새로운 시스템인 미로 캔버스(Miro Canvas)를 발표했습니다.

사용 가능한 커스터마이징

TechSci Research는 정해진 시장 데이터를 이용하여 기업의 특정 요구에 따라 맞춤형으로 제공합니다. 보고서에서 다음과 같은 커스터마이징이 가능합니다.

회사 소개

  • 추가 시장 진입 기업(최대 5개사)에 대한 심층 분석 및 프로파일링

목차

제1장 개요

  • 시장의 정의
  • 시장 범위
    • 대상 시장
    • 조사 대상 연도
    • 주요 시장 세분화

제2장 조사 방법

  • 조사 목적
  • 베이스라인 조사 방법
  • 주요 산업 파트너
  • 주요 협회와 2차 정보 출처
  • 예측 방법
  • 데이터 삼각측량과 검증
  • 가정과 한계

제3장 주요 요약

  • 시장 개요
  • 주요 시장 세분화 개요
  • 주요 시장 기업 개요
  • 주요 지역/국가 개요
  • 시장 성장 촉진요인, 과제, 동향 개요

제4장 임상시험 분석

  • 진행중인 임상시험
  • 완료한 임상시험
  • 종료한 임상시험
  • 파이프라인의 개발 단계별 내역
  • 파이프라인 상황별 내역
  • 파이프라인 내역, 시험 유형별
  • 파이프라인의 지역별 내역
  • 임상시험 히트맵

제5장 VOC(고객의 소리)

제6장 핵산 샘플 조제 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 기술 분야
    • 치료 분야
    • 용도별
    • 최종사용자별
    • 기업별(2022년)
    • 지역별
  • 제품 시장 맵

제7장 아시아태평양의 핵산 샘플 조제 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 기술 분야
    • 치료 분야
    • 용도별
    • 최종사용자
    • 국가별
  • 아시아태평양 국가별 분석
    • 중국
    • 인도
    • 한국
    • 일본
    • 호주

제8장 유럽의 핵산 샘플 조제 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 기술 분야
    • 치료 분야
    • 용도별
    • 최종사용자
    • 국가별
  • 유럽 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제9장 북미의 핵산 샘플 조제 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 기술 분야
    • 치료 분야
    • 용도별
    • 최종사용자
    • 국가별
  • 북미 국가별 분석
    • 미국의 핵산 샘플 조제 시장 전망
      • 시장 규모와 예측
        • 금액별
      • 시장 점유율과 예측
        • 제품별
        • 기술 분야
        • 치료 분야
        • 용도별
        • 최종사용자
    • 멕시코의 핵산 샘플 조제 시장 전망
      • 시장 규모와 예측
        • 금액별
      • 시장 점유율과 예측
        • 제품별
        • 기술 분야
        • 치료 분야
        • 용도별
        • 최종사용자
    • 캐나다의 핵산 샘플 조제 시장 전망
      • 시장 규모와 예측
        • 금액별
      • 시장 점유율과 예측
        • 제품별
        • 기술 분야
        • 치료 분야
        • 용도별
        • 최종사용자

제10장 남미의 핵산 샘플 조제 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 기술 분야
    • 치료 분야
    • 용도별
    • 최종사용자
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동 및 아프리카의 핵산 샘플 조제 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별
    • 기술별
    • 치료 분야
    • 용도별
    • 최종사용자
    • 국가별
  • MEA : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제12장 시장 역학

  • 성장 촉진요인
  • 과제

제13장 시장 동향과 발전

  • 최근의 동향
  • 인수합병
  • 제품 개발

제14장 경쟁 상황

  • Business Overview
  • Company Snapshot
  • Products & Services
  • Financials(In case of listed companies)
  • Recent Developments
  • SWOT Analysis
    • BGI Group(MGI Tech Co., Ltd.)
    • F. Hoffmann-La Roche Ltd
    • Danaher.(Beckman Coulter, Inc.)
    • Eppendorf SE
    • Bioneer Corporation
    • Endress+Hauser Group Services AG(Analytik Jena GmbH)
    • Merck KGaA
    • Norgen Biotek Corp
    • Aurora Biomed Inc.
    • Agilent Technologies, Inc

제15장 전략적 제안

ksm 23.08.23

Nucleic Acid Sample Preparation Market is expected to register an impressive CAGR during the forecast period of 2024-2028. This can be attributed to factors such as the growing usage of nucleic acid molecules in various therapeutic areas.

Moreover, other factors, such as growing advancement in nucleic acid extraction and isolation techniques and growing demand for downstream applications such as Next Generation Sequencing (NGS), targeted sequencing, etc., drive the growth of the Nucleic Acid Sample Preparation market.

Growing Research & Development in Life Sciences

Increasing investment by the government, academics & institutions, etc., to expand research in life science is expected to drive the market demand for the Nucleic Acid Sample Preparation market. For instance, in February 2022, Brightlamp Inc. and Purdue-affiliated Amplified Sciences LLC received a grant of approximately US$ 250,000 each from the Purdue Foundry Investment Fund for R&D to bring advancement in life sciences. The Amplifies Sciences is researching advancing technology for pre-diagnosis of cancer and other diseases. Similarly, Brightlamp is a company that utilizes machine learning and computer vision to enhance and improve healthcare.

Growing Usage of Nucleic Acid in Therapeutic Areas

With the growing demand for disease diagnosis on time and the need for diagnostic information in several patient treatments, distinct molecular procedures are developed and thus are increasing the nucleic acid sample extraction to follow the diagnosis procedures and is anticipated to offer lucrative demand to the nucleic acid sample preparation market. Moreover, the growing prevalence of chronic diseases such as cancer is increasing the need for diagnosis at the molecular level, and thus increase in demand for nucleic acid sample extraction and preparation is driving the market growth during the forecast period. Moreover, sample preparation is an essential application in precision medicine on account of its safety assurance level and successful use of tailored therapies.

Growing Demand for Nucleic Acid Extraction Systems

Nucleic acid isolation /extraction is the most basic step involved in molecular diagnosis or any molecular laboratory research and is expanding with the availability of a distinct range of equipment and methods used for the extraction of samples. The availability of automated nucleic acid extraction systems is bolstering the market growth for the nucleic acid sample preparation market. Moreover, increased automation has leads to running multiple samples at the same time with minimum error ratio and also can extract nucleic acid from distinct samples, such as serum and tissue, cell culture and thus is expected to accelerate the Nucleic Acid Sample Preparation Market. For instance, in February 2020, the market player Covaris Inc. introduced two new kits for viral RNA extraction with throat or nasal swab collection devices, which include the truXTRAC-PCR Direct viral RNA Extraction kit and truXTRAC Viral RNA Extraction kit.

Growing demand for Next generation Sequencing (Downstream applications)

The increased demand for Next-generation Sequencing (NGS) in disease is propelling the demand for the Nucleic Acid Sample Preparation market. The gene or targeted sequence carries a gene or interest or a disease carrier and thus can be identified and used in disease diagnosing. Additionally, targeted sequencing allows researchers to target particular genes of interest, coding areas, and even chromosomal segments, making it a useful technique for sequencing in order to collect accurate, quick, and precise data. The availability of kits and developed reagents for sequencing procedures is attributed to support the market growth and bolster the Nucleic Acid Sample Preparation market during the forecast period.

Recent Developments

Key market players are introducing their new products and expanding their product portfolio. For instance, in February 2020, Miroculus Inc. introduced its Miro Canvas -a new system that can automate, simplify and miniaturize complex protocols like nest generation sequencing library preparation.

Market Segmentation

The Nucleic Acid Sample Preparation Market is segmented based on product, technology, therapeutic area, application, end users, and region. Based on product, the market is further segmented into consumables, systems, and accessories & components. Based on technology, the market is further segmented into spin-column-based technology, magnetic-bead-based technology, and others. Based on Therapeutic Area, the market is segmented into oncology, infectious disease, human genetics/population genetics, and others. Based on application, the market is further segmented into genomics, proteomics, and others. Based on end users, the market is further segmented into end users (academic and research institutions, pharmaceutical and biotechnology companies, clinical and diagnostic laboratories, and others. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

BGI Group (MGI Tech Co., Ltd.), F. Hoffmann-La Roche Ltd, Danaher. (Beckman Coulter, Inc.), Eppendorf SE, Bioneer Corporation, Endress+Hauser Group Services AG (Analytik Jena GmbH), Merck KGaA, Norgen Biotek Corp, Aurora Biomed Inc., Agilent Technologies, Inc., are some of the major players operating in the global nucleic acid sample preparation Market.

Report Scope

In this report, Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Nucleic Acid Sample Preparation, By Product:

  • Consumables
  • Systems
  • Accessories & Components

Nucleic Acid Sample Preparation, By Technology:

  • Spin-Column-Based Technology
  • Magnetic-Bead Based Technology
  • Others

Nucleic Acid Sample Preparation, By Therapeutic Area:

  • Oncology
  • Infectious Disease
  • Human Genetics/Population Genetics
  • Others

Nucleic Acid Sample Preparation, By Application:

  • Genomics
  • Proteomics
  • Others

Nucleic Acid Sample Preparation, By End Users:

  • Academic and Research Institutions
  • Pharmaceutical
  • Biotechnology Companies
  • Clinical and Diagnostic Laboratories
  • Other

Nucleic Acid Sample Preparation, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Nucleic Acid Sample Preparation market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Clinical Trial Analysis

  • 4.1. Ongoing Clinical Trials
  • 4.2. Completed Clinical Trials
  • 4.3. Terminated Clinical Trials
  • 4.4. Breakdown of Pipeline, By Development Phase
  • 4.5. Breakdown of Pipeline, By Status
  • 4.6. Breakdown of Pipeline, By Study Type
  • 4.7. Breakdown of Pipeline, By Region
  • 4.8. Clinical Trials Heat Map

5. Voice of Customer

6. Nucleic Acid Sample Preparation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Consumables, Systems and Accessories & Components)
    • 6.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology and Others)
    • 6.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
    • 6.2.4. By Application (Genomics, Proteomics and Others)
    • 6.2.5. By End Users (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories and Other)
    • 6.2.6. By Company (2022)
    • 6.2.7. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Nucleic Acid Sample Preparation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. Product
    • 7.2.2. Technology
    • 7.2.3. Therapeutic Area
    • 7.2.4. Application
    • 7.2.5. End Users
    • 7.2.6. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Nucleic Acid Sample Preparation Market Outlook.
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. Product
        • 7.3.1.2.2. Technology
        • 7.3.1.2.3. Therapeutic Area
        • 7.3.1.2.4. Application
        • 7.3.1.2.5. End Users
    • 7.3.2. India Nucleic Acid Sample Preparation Market Outlook.
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. Product
        • 7.3.2.2.2. Technology
        • 7.3.2.2.3. Therapeutic Area
        • 7.3.2.2.4. Application
        • 7.3.2.2.5. End Users
    • 7.3.3. South Korea Nucleic Acid Sample Preparation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. Product
        • 7.3.3.2.2. Technology
        • 7.3.3.2.3. Therapeutic Area
        • 7.3.3.2.4. Application
        • 7.3.3.2.5. End Users
    • 7.3.4. Japan Nucleic Acid Sample Preparation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. Product
        • 7.3.4.2.2. Technology
        • 7.3.4.2.3. Therapeutic Area
        • 7.3.4.2.4. Application
        • 7.3.4.2.5. End Users
    • 7.3.5. Australia Nucleic Acid Sample Preparation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. Product
        • 7.3.5.2.2. Technology
        • 7.3.5.2.3. Therapeutic Area
        • 7.3.5.2.4. Application
        • 7.3.5.2.5. End Users

8. Europe Nucleic Acid Sample Preparation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. Product
    • 8.2.2. Technology
    • 8.2.3. Therapeutic Area
    • 8.2.4. Application
    • 8.2.5. End Users
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Nucleic Acid Sample Preparation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. Product
        • 8.3.1.2.2. Technology
        • 8.3.1.2.3. Therapeutic Area
        • 8.3.1.2.4. Application
        • 8.3.1.2.5. End Users
    • 8.3.2. Germany Nucleic Acid Sample Preparation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. Product
        • 8.3.2.2.2. Technology
        • 8.3.2.2.3. Therapeutic Area
        • 8.3.2.2.4. Application
        • 8.3.2.2.5. End Users
    • 8.3.3. United Kingdom Nucleic Acid Sample Preparation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. Product
        • 8.3.3.2.2. Technology
        • 8.3.3.2.3. Therapeutic Area
        • 8.3.3.2.4. Application
        • 8.3.3.2.5. End Users
    • 8.3.4. Italy Nucleic Acid Sample Preparation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. Product
        • 8.3.4.2.2. Technology
        • 8.3.4.2.3. Therapeutic Area
        • 8.3.4.2.4. Application
        • 8.3.4.2.5. End Users
    • 8.3.5. Spain Nucleic Acid Sample Preparation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. Product
        • 8.3.5.2.2. Technology
        • 8.3.5.2.3. Therapeutic Area
        • 8.3.5.2.4. Application
        • 8.3.5.2.5. End Users

9. North America Humic-based bio stimulants Market Outlook.

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. Product
    • 9.2.2. Technology
    • 9.2.3. Therapeutic Area
    • 9.2.4. Application
    • 9.2.5. End Users
    • 9.2.6. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Nucleic Acid Sample Preparation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. Product
        • 9.3.1.2.2. Technology
        • 9.3.1.2.3. Therapeutic Area
        • 9.3.1.2.4. Application
        • 9.3.1.2.5. End Users
    • 9.3.2. Mexico Nucleic Acid Sample Preparation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. Product
        • 9.3.2.2.2. Technology
        • 9.3.2.2.3. Therapeutic Area
        • 9.3.2.2.4. Application
        • 9.3.2.2.5. End Users
    • 9.3.3. Canada Nucleic Acid Sample Preparation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. Product
        • 9.3.3.2.2. Technology
        • 9.3.3.2.3. Therapeutic Area
        • 9.3.3.2.4. Application
        • 9.3.3.2.5. End Users

10. South America Nucleic Acid Sample Preparation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. Product
    • 10.2.2. Technology
    • 10.2.3. Therapeutic Area
    • 10.2.4. Application
    • 10.2.5. End Users
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. Product
        • 10.3.1.2.2. Technology
        • 10.3.1.2.3. Therapeutic Area
        • 10.3.1.2.4. Application
        • 10.3.1.2.5. End Users
    • 10.3.2. Argentina Nucleic Acid Sample Preparation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. Product
        • 10.3.2.2.2. Technology
        • 10.3.2.2.3. Therapeutic Area
        • 10.3.2.2.4. Application
        • 10.3.2.2.5. End Users
    • 10.3.3. Colombia Nucleic Acid Sample Preparation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. Product
        • 10.3.3.2.2. Technology
        • 10.3.3.2.3. Therapeutic Area
        • 10.3.3.2.4. Application
        • 10.3.3.2.5. End Users

11. Middle East and Africa Nucleic Acid Sample Preparation Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. Product
    • 11.2.2. Technology
    • 11.2.3. Therapeutic Area
    • 11.2.4. Application
    • 11.2.5. End Users
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Nucleic Acid Sample Preparation Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. Product
        • 11.3.1.2.2. Technology
        • 11.3.1.2.3. Therapeutic Area
        • 11.3.1.2.4. Application
        • 11.3.1.2.5. End Users
    • 11.3.2. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. Product
        • 11.3.2.2.2. Technology
        • 11.3.2.2.3. Therapeutic Area
        • 11.3.2.2.4. Application
        • 11.3.2.2.5. End Users
    • 11.3.3. UAE Nucleic Acid Sample Preparation Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. Product
        • 11.3.3.2.2. Technology
        • 11.3.3.2.3. Therapeutic Area
        • 11.3.3.2.4. Application
        • 11.3.3.2.5. End Users
    • 11.3.4. Kuwait Nucleic Acid Sample Preparation Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. Product
        • 11.3.4.2.2. Technology
        • 11.3.4.2.3. Therapeutic Area
        • 11.3.4.2.4. Application
        • 11.3.4.2.5. End Users

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Developments

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Company Snapshot
  • 14.3. Products & Services
  • 14.4. Financials (In case of listed companies)
  • 14.5. Recent Developments
  • 14.6. SWOT Analysis
    • 14.6.1. BGI Group (MGI Tech Co., Ltd.)
    • 14.6.2. F. Hoffmann-La Roche Ltd
    • 14.6.3. Danaher. (Beckman Coulter, Inc.)
    • 14.6.4. Eppendorf SE
    • 14.6.5. Bioneer Corporation
    • 14.6.6. Endress+Hauser Group Services AG (Analytik Jena GmbH)
    • 14.6.7. Merck KGaA
    • 14.6.8. Norgen Biotek Corp
    • 14.6.9. Aurora Biomed Inc.
    • 14.6.10. Agilent Technologies, Inc

15. Strategic Recommendations

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제